Barentz Acquires Gangwal in India
Barentz International, a leading global life science ingredients distributor announced an agreement to acquire a majority stake in the distribution
A forum for researchers, students and applicants in the field of cyclodextrin technology
Barentz International, a leading global life science ingredients distributor announced an agreement to acquire a majority stake in the distribution
Professor Wu Dianquing at Yale university has discovered that a widely used anticancer drug, pazopanib might be suitable for treating
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through
Effects of CDs exerted on cellular functions are generally thought to originate from reductions in cholesterol levels. Potential direct, ligand-like
Cyclo Therapeutics, Inc., a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and
Pfizer’s breakthrough drug candidate PF-07321332 used in combination with ritonavir was poven to successfully reduce the risk of hospitalization and
OrganoTherapeutics in collaboration with University of Luxemburg has published interestingin vitro and in vivo results on the effects of HPBCD
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects more than 10 million people worldwide. Oxidative stress and mitochondrial
After the great success of the webinar held in May, 2021 a next webinar organized by CycloLab will be held
Large ring cyclodextrins were prepared and studied as alternatives for drug solubilization [1]. A mixture of CD22-48 was compared with